Rapport Therapeutics, Inc. Common Stock beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.87 | — | — | Miss |
| Q12026 FY2026 | $-0.56 | $-0.42 | +25.0% | Beat |
| 2026-03-10 | $-0.65 | — | — | Miss |
Back to RAPP overview · RAPP holders · RAPP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.